Merendino Lauren — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Merendino Lauren has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $93K.

Profile

Lauren Merendino is the Chief Commercial Officer at Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing targeted therapies for genetically defined cancers, particularly in pediatric patients. She has been involved in the company's commercial strategies as it seeks to address unmet needs in cancer treatment.

Board memberships

• Day One Biopharmaceuticals, Inc.

Awards & honors

• Chief Commercial Officer at Day One Biopharmaceuticals

Recent Transactions

Companies — Last 90 Days

• Day One Biopharmaceuticals, Inc. (DAWN) — 1 filings, last 2026-04-23

Frequently Asked Questions

Who is Merendino Lauren?

Lauren Merendino is the Chief Commercial Officer at Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing targeted therapies for genetically defined cancers, particularly in pediatric patients. She has been involved in the company's commercial strategies as it seeks to address unmet needs in cancer treatment.…

How many SEC Form 4 filings has Merendino Lauren submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Merendino Lauren been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($93K) across all tracked filings.

Where can I see all of Merendino Lauren's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week